Top Markets
Coin of the day
BELLUS Health Inc. BELLUS Health Inc.

BELLUS Health Inc.

BLU
Rangering i aksjer #6896
BELLUS Health Inc. is a biopharmaceutical firm in the clinical development... BELLUS Health Inc. is a biopharmaceutical firm in the clinical development phase, dedicated to creating new therapeutic options for intractable chronic cough (RCC) and various other conditions characterized by heightened cough sensitivity. The company's primary investigational compound, BLU-5937, functions as a P2X3 receptor antagonist. This drug is currently progressing through Phase II clinical trials, where it is being assessed for its potential in treating both RCC and persistent itching. Founded in 1993, BELLUS Health Inc. is headquartered in Laval, Canada.
Aksjekurs
$14.30
Sist synkronisert: 2023-06-29
Markedsverdi
$1.81B
Endring (1 dag)
-2.81%
Endring (1 år)
0.00%
Land
CA
Handel BELLUS Health Inc. (BLU)

Kategori

Historikk for aksjesplitt for BELLUS Health Inc. (BLU)
Aksjen BELLUS Health Inc. (symbol: BLU) har gjennomgått totalt 0 aksjesplitt.
Den nyeste splittelsen skjedde Aug 28, 2026.
Én BLU-aksje kjøpt før Aug 28, 2026 tilsvarer i dag 0 BLU-aksjer.
Liste over aksjesplitt
År Splitt Multiplikator Kumulativ multiplikator
Ikke nok data for de angitte datoene.
Aksjesplitt for lignende selskaper eller konkurrenter
Selskap Antall aksjesplitt Kumulativ multiplikator Land
1 x2
US
0 -
NL
1 x3
AU
0 -
US
0 -
CH